| Accession Number | 0001140361-26-034238 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 25, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President&Immunovant CEO | Common Shares | โ | Aug 20, 2026 | Tax Withholding | 13,909 | $36.84 | $512,407.56 | 1,599,154 | Direct | โ | View Details |